Robert W Duggan
Co-Chief Executive Officer, Director, 10% owner, Summit Therapeutics Inc.; Director, 10% owner, Pulse Biosciences, Inc.
Bought, 12 months
$64.4M
Sold, 12 months
$0.0M
Companies
2
Latest trade
Jun 12, 2026
Companies
Summit Therapeutics Inc.Co-Chief Executive Officer, Director, 10% owner +$51.9M Pulse Biosciences, Inc.Director, 10% owner +$13.0MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

